Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation
Patients undergoing antiviral therapy for chronic hepatitis C often develop anemia secondary to ribavirin and interferon. Recombinant erythropoietin has been used to improve anemia associated with antiviral therapy and to minimize dose reductions, which are associated with decreased rates of sustain...
Main Authors: | Annie K. Hung, Jennifer Guy, Caroline M. Behler, Eugene E. Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Transplantation |
Online Access: | http://dx.doi.org/10.1155/2015/286276 |
Similar Items
-
PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN
by: MIhajlovic Filip, et al.
Published: (2018-05-01) -
Acquired pure red cell aplasia and recombinant erythropoietin
by: Somanath Padhi, et al.
Published: (2021-01-01) -
Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review
by: Gabriela Lacreta, et al.
Published: (2018-08-01) -
Acquired pure red cell aplasia following recombinant erythropoietin (darbepoetin-alfa) therapy
by: Somanath Padhi, et al.
Published: (2020-01-01) -
Ten year follow up of erythropoietin induced autoimmune pure red cell aplasia
by: R Ram, et al.
Published: (2013-01-01)